Photo taken on Feb. 28, 2021 shows the traditional Chinese medicine Lianhua Qingwen Capsules at a pharmacy in Kuwait City, Kuwait. (Photo by Asad/Xinhua)
BEIJING, May 12 (Xinhua) -- Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced on Wednesday that it has received the herbal drug registration certificate for Lianhua Qingwen Capsules, a traditional Chinese medicine (TCM) product, from Nigeria's National Agency for Food and Drug Administration and Control.
According to the company, Nigeria is the eighth African country issuing market entry approval for Lianhua Qingwen. Up to now, Lianhua Qingwen has got market entry approvals from 29 countries and regions, including Canada, Russia, Kuwait, Singapore, Kenya, etc.
"In recent years, Yiling Pharmaceutical has been actively promoting various innovative Traditional Chinese Medicine (TCM) products globally, including Lianhua Qingwen, a recommended patent TCM for the treatment of COVID-19", an expert with Yiling Pharmaceutical was quoted as saying by Shanghai Securities News.
It is reported that Yiling Pharmaceutical's overseas revenue rose 17 percent year on year in 2021.
(Edited by Li Shimeng with Xinhua Silk Road, lishimeng@xinhua.org)
A single purchase
